0001127602-12-015945.txt : 20120504
0001127602-12-015945.hdr.sgml : 20120504
20120504163127
ACCESSION NUMBER: 0001127602-12-015945
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120502
FILED AS OF DATE: 20120504
DATE AS OF CHANGE: 20120504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLACKSON TIMOTHY P
CENTRAL INDEX KEY: 0001242992
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21696
FILM NUMBER: 12814731
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0305
4
2012-05-02
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001242992
CLACKSON TIMOTHY P
C/O ARIAD PHARMACEUTICALS INC
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
President, R&D, CSO
Common Stock
2012-05-02
4
M
0
20000
7.44
A
253778
D
Common Stock
2012-05-02
4
S
0
20000
17.00
D
233778
D
Employee Stock Option (Right to Buy)
7.44
2012-05-02
4
M
0
20000
0
D
2004-06-23
2014-06-23
Common Stock
20000
0
D
Shares were acquired upon the exercise of outstanding stock options at $7.44 per share.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011.
/s/Edward M. Fitzgerald, Attorney-in-Fact
2012-05-03